Highlight Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Highlight Therapeutics?

Highlight Therapeutics has 5 investors including Buenavista Equity Partners And Centre for the Development of Industrial Technology (CDTI).

Q: How much funding has Highlight Therapeutics raised to date?

Highlight Therapeutics has raised obfuscated.

Overview

Highlight Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Highlight Therapeutics

CB Rank

35536

Highlight Therapeutics is a clinical-stage biopharmaceutical company.

Founded

obfuscation

Private

Venture - Series Unknown

Paterna, Comunidad Valenciana, Spain

1-10

www.highlighttherapeutics.com/

Biopharma

Biotechnology

Health Care

Medical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Marisol Quintero: CEO
Past Role: Fundacion Botin, Technology Transfer Manager
Damià Tormo: Co-Founder

Details

Legal Name

Highlight Therapeutics, S.L.

Also Known As

Bioncotech

Operating Status

Active

Company Type

For Profit

Founders

Damià Tormo, Maria Gonzalez

About the Company

Highlight Therapeutics is a private, clinical-stage company dedicated to unlocking the full potential of immuno-oncology.

Phone Number

34 961 10 99 55

Contact Email

info@highlighttherapeutics.com

Predictions & Insights

Growth Insight

See this Growth Insight

Highlight Therapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

BO-112

An intra-lesional RNA-based therapy designed to activate the immune system to recognize and attack cancer cells by converting immunologically 'cold' tumors into 'hot' tumors.

BO-212

A pre-clinical immunotherapy candidate under development aimed at treating solid tumors through immune system activation.

Research & Development

Highlight Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Highlight Therapeutics	1	obfuscated obfuscation	Buenavista Equity Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Highlight Therapeutics	1	obfuscated obfuscation	Buenavista Equity Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Highlight Therapeutics	1	obfuscated obfuscation	Buenavista Equity Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Highlight Therapeutics	1	obfuscated obfuscation	Buenavista Equity Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Highlight Therapeutics	1	obfuscated obfuscation	Buenavista Equity Partners	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Highlight Therapeutics	1	obfuscated obfuscation	Buenavista Equity Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Highlight Therapeutics	1	obfuscated obfuscation	Buenavista Equity Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Highlight Therapeutics	1	obfuscated obfuscation	Buenavista Equity Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Highlight Therapeutics	1	obfuscated obfuscation	Buenavista Equity Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Highlight Therapeutics	1	obfuscated obfuscation	Buenavista Equity Partners	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Buenavista Equity Partners	Yes	Venture Round - Highlight Therapeutics	Nuria Oses Mugica
Buenavista Equity Partners	Yes	Venture Round - Highlight Therapeutics	Nuria Oses Mugica
Buenavista Equity Partners	Yes	Venture Round - Highlight Therapeutics	Nuria Oses Mugica
Buenavista Equity Partners	Yes	Venture Round - Highlight Therapeutics	Nuria Oses Mugica
Buenavista Equity Partners	Yes	Venture Round - Highlight Therapeutics	Nuria Oses Mugica